Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
International Specialty Products (ISP) was a leading global manufacturer of specialty chemicals and performance-enhancing ingredients for the pharmaceutical, personal care, and industrial markets. In the life sciences sector, the company was renowned for its extensive portfolio of pharmaceutical excipients, including binders, disintegrants, and solubilizers such as Povidone (PVP) and Crospovidone. ISP's products were critical components in drug formulation, enhancing the stability and delivery of both oral solids and liquid dosage forms. The company was acquired by Ashland Inc. in 2011, integrating its high-value pharmaceutical ingredients into Ashland's specialty ingredients business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ISP.